These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 11509489

  • 1. Age-related reduction of NO availability and oxidative stress in humans.
    Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A.
    Hypertension; 2001 Aug; 38(2):274-9. PubMed ID: 11509489
    [Abstract] [Full Text] [Related]

  • 2. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, Salvetti A.
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [Abstract] [Full Text] [Related]

  • 3. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes.
    Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C, Salvetti A.
    Circulation; 2000 Jun 27; 101(25):2896-901. PubMed ID: 10869260
    [Abstract] [Full Text] [Related]

  • 4. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
    Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A.
    Circulation; 1995 Nov 15; 92(10):2911-8. PubMed ID: 7586259
    [Abstract] [Full Text] [Related]

  • 5. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A.
    Circulation; 1998 Jun 09; 97(22):2222-9. PubMed ID: 9631871
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension.
    Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A.
    J Am Coll Cardiol; 2001 Oct 09; 38(4):1106-15. PubMed ID: 11583890
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Giannarelli C, De Negri F, Virdis A, Ghiadoni L, Cipriano A, Magagna A, Taddei S, Salvetti A.
    Hypertension; 2007 Apr 09; 49(4):878-84. PubMed ID: 17339540
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A.
    Hypertension; 1997 Jan 09; 29(1 Pt 2):274-9. PubMed ID: 9039114
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
    Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S, Salvetti A.
    Circulation; 2000 May 16; 101(19):2258-63. PubMed ID: 10811592
    [Abstract] [Full Text] [Related]

  • 11. Hypertension causes premature aging of endothelial function in humans.
    Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, Salvetti A.
    Hypertension; 1997 Mar 16; 29(3):736-43. PubMed ID: 9052889
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
    Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F.
    J Clin Endocrinol Metab; 2003 Aug 16; 88(8):3731-7. PubMed ID: 12915662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
    Schlaich MP, Ahlers BA, Parnell MM, Kaye DM.
    J Hypertens; 2004 Oct 16; 22(10):1917-25. PubMed ID: 15361763
    [Abstract] [Full Text] [Related]

  • 17. Basal nitric oxide production is impaired in offspring of patients with essential hypertension.
    McAllister AS, Atkinson AB, Johnston GD, Hadden DR, Bell PM, McCance DR.
    Clin Sci (Lond); 1999 Aug 16; 97(2):141-7. PubMed ID: 10409468
    [Abstract] [Full Text] [Related]

  • 18. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Pasini AF, Garbin U, Cominacini L, Salvetti A.
    J Hypertens; 2001 Aug 16; 19(8):1379-86. PubMed ID: 11518845
    [Abstract] [Full Text] [Related]

  • 19. Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase.
    Virdis A, Duranti E, Colucci R, Ippolito C, Tirotta E, Lorenzini G, Bernardini N, Blandizzi C, Taddei S.
    Eur Heart J; 2015 Nov 14; 36(43):3023-30. PubMed ID: 26224075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.